Who Owns Estrella Immunopharma Stock?
NASDAQ: ESLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 11:46 AM ET
Ownership breakdown
- Held by institutions
- 11.14%
- Held by insiders
- 60.42%
- Institutional holders
- 18
- Institutions 11.1%
- Insiders 60.4%
- Public and other 28.4%
Who owns Estrella Immunopharma stock?
Institutional investors own about 11.1% of Estrella Immunopharma's shares, spread across 18 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 60.42% of ESLA.
The largest institutional holders are Armistice Capital, LLC (9.14%), Vanguard Capital Management LLC (0.96%) and Geode Capital Management, LLC (0.32%). Together, the top 10 institutions control 11.0% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their ESLA positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ESLA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Armistice Capital, LLC | 3.98M | 9.14% | -3.0% |
| Vanguard Capital Management LLC | 416.85K | 0.96% | +9.0% |
| Geode Capital Management, LLC | 141.32K | 0.32% | -10.3% |
| Vanguard Fiduciary Trust Co | 64.92K | 0.15% | 0.0% |
| Blackrock Inc. | 52.03K | 0.12% | +30.4% |
| State Street Corporation | 43.25K | 0.10% | 0.0% |
| Renaissance Technologies, LLC | 39.10K | 0.09% | -37.7% |
| Northern Trust Corporation | 34.86K | 0.08% | +77.6% |
| US BANCORP \DE\ | 20.00K | 0.05% | +18.3% |
| Tower Research Capital LLC (TRC) | 3.31K | 0.01% | -31.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ESLA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 268.61K | 0.62% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 148.25K | 0.34% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 80.88K | 0.19% |
| iShares Trust-iShares Micro-Cap ETF | 49.33K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 26.16K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 16.76K | 0.04% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 2.37K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Estrella Immunopharma?
Armistice Capital, LLC is the largest institutional shareholder of ESLA, owning 9.14% of shares outstanding (3.98M shares) as of its latest 13F filing.
What percentage of Estrella Immunopharma is owned by institutions?
Institutions own about 11.1% of ESLA shares and 28.1% of the public float.
How much of Estrella Immunopharma do insiders own?
Insiders, such as officers and directors, own about 60.42% of ESLA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.